Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats E. H. HermanJun ZhangVictor J. Ferrans Original Article Pages: 93 - 100
Protein binding of brequinar in the plasma of healthy donors and cancer patients and analysis of the relationship between protein binding and pharmacokinetics in cancer patients Shang-Ying P. KingAllison M. AgraCheck Y. Quon Original Article Pages: 101 - 108
Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells Biserka MitrovskiJosie PressaccoCharles Erlichman Original Article Pages: 109 - 114
Effects of neocarzinostatin upon the development of tumors from murine neuroblastoma cells Patricia WillKathleen A. GugerNina Felice Schor Original Article Pages: 115 - 120
Bioditribution ofO 6-benzylguanine and its effectiveness against human brain tumor xenografts when given in polyethylene glycol or cremophor-EL M. Eileen DolanAnthony E. PeggHenry S. Friedman Original Article Pages: 121 - 126
Busulfan therapy of central nervous system xenografts in athymic mice Rosemary H. AaronGertrude B. ElionHenry S. Friedman Original Article Pages: 127 - 131
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy Bernhard H. LauterburgTrinh NguyenThomas Cerny Original Article Pages: 132 - 136
Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and-resistant human ovarian carcinoma cell lines by amphotericin B Swee Y. SharpPrakash MistryLloyd R. Kelland Original Article Pages: 137 - 143
The pharmacokinetics of reduced folates after intraperltoneal and intravenous administration of racemic [6S,R]-folinic acid Jan H. M. SipsOlaf van TellingenJos H. Beijnen Original Article Pages: 144 - 148
Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance Juhani MaenpaaValerie WiebeMichael DeGregorio Original Article Pages: 149 - 152
Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours Lai-Ming ChingWayne R. JosephBruce C. Baguley Original Article Pages: 153 - 160
Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea James W. RaschkoSteven A. AkmanJames H. Doroshow Original Article Pages: 161 - 164
Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association Gary W. ThomasHyman B. MussRobin Heath Original Article Pages: 165 - 168
Preclinical pharmacology of 1069C85, a novel tubulin binder Florence I. RaynaudLloyd R. KellandIan R. Judson Original Article Pages: 169 - 173
A phase I/II study of 4′-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients Herbert StögerThomas BauernhoferHellmut Samonigg Clinical Trial Report Pages: 174 - 178
Validation of a limited sampling model for carboplatin in a high-dose chemotherapy combination Laurence J. C. van WarmerdamSjoerd RodenhuisJos H. Beijnen Short Communication Pages: 179 - 181
In vitro characterization of the myelotoxicity of cyclopentenyl cytosine Donna A. VolpeDe-lin DuMartin J. Murphy Jr. Erratum Pages: 182 - 182